Sage Journals: Discover world-class research

Abstract

The benefits of improved treatments for cystic fibrosis (CF) depend on optimal adherence, which remains problematic, particularly to aerosol therapy. In this study, we explored the process of adhering to aerosol therapy from the perspective of both adolescents with CF and their parents. Interviews were conducted individually with six adolescents and six parents, informed by accurate adherence data from an electronically chipped, aerosol device. Interview transcripts from audio-recordings were analyzed using grounded theory method (GTM). Major themes revealed differences in perspective between parent and adolescent, with this relationship mediating the cognitive and emotional processes that play a significant role in adherence behavior. These processes are further influenced by interactions with the aerosol therapy treatment regimen, device characteristics, and the context in which adherence is taking place. Parents and adolescents have different views of treatment and how to manage it. Both need to be addressed if optimal adherence is to be achieved.

Keywords

chronic illness and disease respiratory disorders cystic fibrosis children,adolescents psychology,psychological issues health behavior behavior change adherence compliance qualitative grounded theory United Kingdom

Get full access to this article

View all access options for this article.

References

Abbott

Bilton

(2015). Adherence to Ivacaftor is suboptimal. Journal of Cystic Fibrosis, 14, 547–548. doi:10.1016/j.jcf.2015.08.001

Abbott

Hart

(2005). Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: A critical review. Health and Quality of Life Outcomes, 3, Article 19. doi:10.1186/1477-7525-3-19

Arias Lorente

R. P.

Bousono Garcia

Diaz Martin

J. J

. (2008). Treatment compliance in children and adults with cystic fibrosis. Journal of Cystic Fibrosis, 7, 359–367. doi:10.1016/j.jcf.2008.01.003

Barker

Quittner

A. L.

(2010). A biopsychosocial model of cystic fibrosis: Social and emotional functioning, adherence, and quality of life. In Allen

J. L.

Panitch

H. B.

Rubenstein

R. C.

(Eds.), Cystic fibrosis (pp. 468–481). New York: Informa Healthcare.

Bodnár

Mészáros

Oláh

Ágh

(2016). Inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients: Challenges to treatment adherence and strategies to improve outcomes. Patient Preference and Adherence, 10, 183–193. doi:10.2147/ppa.s53653

Briesacher

B. A.

Quittner

A. L.

Saiman

Sacco

Fouayzi

Quittell

L. M.

(2011). Adherence with tobramycin inhaled solution and health care utilization. BMC Pulmonary Medicine, 11, Article 5. doi:10.1186/1471-2466-11-5

Burns

(1989). Standards for qualitative research. Nursing Science Quarterly, 2, 44–52. doi:10.1177/089431848900200112

Charmaz

(2006). Constructing grounded theory: A practical guide through qualitative analysis. London: Sage.

Cystic Fibrosis Trust. (2018). UK cystic fibrosis registry—Annual Data Report 2017. London: Author.

10.

DiMatteo

M. R.

Giordani

P. J.

Lepper

H. S.

Corghan

T. W.

(2002). Patient adherence and medical treatment outcomes: A meta-analysis. Medical Care, 40, 794–811. doi:10.1097/00005650-200209000-00009

11.

Dodge

J. A.

Lewis

P. A.

Stanton

Wilsher

(2007). Cystic fibrosis mortality and survival in the UK: 1947–2003. European Respiratory Journal, 29, 522–526. doi:10.1183/09031936.00099506

12.

Duff

A. J. A.

Latchford

(2010). Motivational interviewing for adherence problems in cystic fibrosis: State of the art review. Pediatric Pulmonology, 45, 211–220. doi:10.1002/ppul.21103

13.

Duff

A. J. A.

Oxley

(2016). Psychology. In Bush

Bilton

Hodson

(Eds.), Hodson and Geddes’ cystic fibrosis (4th ed., pp. 582–597). Boca Raton, FL: Taylor & Francis.

14.

Dziuban

E. J.

Saab-Abazeed

Chaudhry

S. R.

Streetman

D. S.

Nasr

S. Z.

(2010). Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosis. Pediatric Pulmonology, 45, 450–458. doi:10.1002/ppul.21195

15.

Eakin

M. N.

Bilderback

Boyle

M. P.

Mogayzel

P. J.

Riekert

K. A.

(2011). Longitudinal association between medication adherence and lung health in people with cystic fibrosis. Journal of Cystic Fibrosis, 10, 258–264. doi:10.1016/j.jcf.2011.03.005

16.

Feuchtbaum

Carter

Dowray

Currier

R. J.

Lorey

(2012). Birth prevalence of disorders detectable through newborn screening by race/ethnicity. Genetics in Medicine, 14, 937–945. doi:10.1038/gim.2012.76

17.

George

Rand-Giovannetti

Eakin

M. N.

Borrelli

Zettler

Riekert

K. A.

(2010). Perceptions of barriers and facilitators: Self-management decisions by older adolescents and adults with CF. Journal of Cystic Fibrosis, 9, 425–432. doi:10.1016/j.jcf.2010.08.016

18.

Giarelli

Bernhardt

B. A.

Mack

Pyeritz

R. E.

(2008). Adolescents’ transition to self-management of a chronic genetic disorder. Qualitative Health Research, 18, 441–457. doi:10.1177/1049732308314853

19.

MacKenzie

Gifford

A. H.

Sabadosa

K. A.

Quinton

H. B.

Knapp

E. A.

Goss

C. H.

Marshall

B. C.

(2014). Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: Survival analysis of the Cystic Fibrosis Foundation patient registry. Annals of Internal Medicine, 161, 233–241. doi:10.7326/m13-0636

20.

Macneil

S. J.

(2016). Epidemiology of cystic fibrosis. In Bush

Bilton

Hodson

(Eds.), Hodson and Geddes’ cystic fibrosis (4th ed., pp. 18–40). Boca Raton, FL: Taylor & Francis.

21.

McCormack

Southern

McNamara

(2012). New nebulizer technology to monitor adherence and nebulizer performance in cystic fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 25, 307–309. doi:10.1089/jamp.2011.0934

22.

McNamara

P. S.

McCormack

McDonald

A. J.

Heaf

Southern

K. W.

(2009). Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis. Journal of Cystic Fibrosis, 8, 258–263. doi:10.1016/j.jcf.2009.04.006

23.

Narayanan

Mainz

J. G.

Gala

Tabori

Grossoehme

(2017). Adherence to therapies in cystic fibrosis: A targeted literature review. Expert Review of Respiratory Medicine, 11, 129–145. doi:10.1080/17476348.2017.1280399

24.

Osterberg

Blaschke

(2005). Adherence to medication. The New England Journal of Medicine, 353, 487–497. doi:10.1056/nejmra050100

25.

Quittner

A. L.

Abbott

Georgiopoulos

A. M.

Goldbeck

Smith

Hempstead

S. E.

. . . Elborn

(2016). International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax, 71, 26–34. doi:10.1136/thoraxjnl-2015-207488

26.

Quittner

A. L.

Goldbeck

Abott

Duff

A. J.

Lambrecht

Sole

Tibosch

(2014). Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: Results of the International Depression Epidemiological Study across nine countries. Thorax, 69, 1090–1097. doi:10.1136/thoraxjnl-2014-205983

27.

Quittner

A. L.

Modi

A. C.

Lemanek

K. L.

Ievers-Landis

C. E.

Rapoff

M. A.

(2008). Evidence-based assessment of adherence to medical treatments in pediatric psychology. Journal of Pediatric Psychology, 33, 916–936. doi:10.1093/jpepsy/jsm064

28.

Quittner

A. L.

Zhang

Marynchenko

Chopra

P. A.

Signorovitch

Yushkina

Riekert

K. A.

(2014). Pulmonary medication adherence and health-care use in cystic fibrosis. Chest, 146, 142–151. doi:10.1378/chest.13-1926

29.

Ratjen

Bell

S. C.

Rowe

S. M.

Goss

C. H.

Quittner

A. L.

Bush

(2015). Cystic fibrosis. Nature Reviews Disease Primers, 1, Article 15010. doi:10.1038/nrdp.2015.10

30.

Reis

H. T.

Gable

S. L.

(2000). Event-sampling and other methods for studying everyday experience. In Reis

H. T.

Judd

C. M.

(Eds.), Handbook of research methods in social and personality psychology (pp. 190–222). New York: Cambridge University Press.

31.

Rowbotham

N. J.

Smith

Leighton

P. A.

Rayner

O. C.

Gathercole

Elliott

Z. C.

. . . Smyth

A. R.

(2017). The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers. Thorax, 73, 388–390. doi:10.1136/thoraxjnl-2017-210473

32.

Sawicki

G. S.

Goss

C. H.

(2015). Tackling the increasing complexity of CF care. Pediatric Pulmonology, 50, S74–S79. doi:10.1002/ppul.23244

33.

Sawicki

G. S.

Sellers

D. E.

Robinson

W. M.

(2008). High treatment burden in adults with cystic fibrosis: Challenges to disease self-management. Journal of Cystic Fibrosis, 8, 91–96. doi:10.1016/j.jcf.2008.09.007

34.

Schechter

Ostrenga

Fink

Barker

Quittner

(2017). Five year survival is decreased in CF patients who screen positive for depression. Pediatric Pulmonology, 52, S404–S505. doi:10.1002/ppul.v52.s47

35.

Strauss

A. L.

Corbin

(1990). Basics of qualitative research: Grounded theory procedures and techniques. Newbury Park CA: Sage.

36.

Yeh

E. A.

Chiang

Darshan

Nejati

Grover

S. A.

Schwartz

C. E.

, . . . Pediatric MS Adherence Study Group. (2018). Adherence in youth with multiple sclerosis: A qualitative assessment of habit formation, barriers, and facilitators. Qualitative Health Research. Advance online publication. doi:10.1177/1049732318779039

Adherence to Aerosol Therapy in Young People With Cystic Fibrosis: Patient and Parent Perspectives Following Electronic Data Capture

Abstract

Keywords

Get full access to this article

References